Selected research
Industry Growth & Trends
Global Placenta Growth Factor Industry Growth and Trends Forecast to 2032
Market perspective
The global Placenta Growth Factor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Placenta Growth Factor include Alteogen Inc., Clearside BioMedical, Inc., Formycon AG, Regeneron Pharmaceuticals Inc, ThromboGenics NV and Chengdu Kanghong Pharmaceuticals Group Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Placenta Growth Factor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Placenta Growth Factor market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Placenta Growth Factor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Placenta Growth Factor.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Placenta Growth Factor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Placenta Growth Factor Market by Company
Alteogen Inc.
Clearside BioMedical, Inc.
Formycon AG
Regeneron Pharmaceuticals Inc
ThromboGenics NV
Chengdu Kanghong Pharmaceuticals Group Co Ltd
Placenta Growth Factor Segment by Type
SL-186
SL-188
Aflibercept
Aflibercept Biosimilar
Others
Placenta Growth Factor Segment by Application
Neovascular Glaucoma
Myopia
Branch Retinal Vein Occlusion
Others
Placenta Growth Factor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Placenta Growth Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Placenta Growth Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Placenta Growth Factor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placenta Growth Factor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Placenta Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- SL-186
- SL-188
- Aflibercept
- Aflibercept Biosimilar
- Others
Applications
- Neovascular Glaucoma
- Myopia
- Branch Retinal Vein Occlusion
- Others
Companies covered
- Alteogen Inc.
- Clearside BioMedical, Inc.
- Formycon AG
- Regeneron Pharmaceuticals Inc
- ThromboGenics NV
- Chengdu Kanghong Pharmaceuticals Group Co Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Placenta Growth Factor Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Placenta Growth Factor Sales Estimates and Forecasts (2021-2032)
- 1.3 Placenta Growth Factor Market by Type
- 1.3.1 SL-186
- 1.3.2 SL-188
- 1.3.3 Aflibercept
- 1.3.4 Aflibercept Biosimilar
- 1.3.5 Others
- 1.4 Global Placenta Growth Factor Market Size by Type
- 1.4.1 Global Placenta Growth Factor Market Size Overview by Type (2021-2032)
- 1.4.2 Global Placenta Growth Factor Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Placenta Growth Factor Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Placenta Growth Factor Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Placenta Growth Factor Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Placenta Growth Factor Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Placenta Growth Factor Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Placenta Growth Factor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Placenta Growth Factor Industry Trends
- 2.2 Placenta Growth Factor Industry Drivers
- 2.3 Placenta Growth Factor Industry Opportunities and Challenges
- 2.4 Placenta Growth Factor Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Placenta Growth Factor Revenue (2021-2026)
- 3.2 Global Top Players by Placenta Growth Factor Sales (2021-2026)
- 3.3 Global Top Players by Placenta Growth Factor Price (2021-2026)
- 3.4 Global Placenta Growth Factor Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Placenta Growth Factor Major Company Production Sites & Headquarters
- 3.6 Global Placenta Growth Factor Company, Product Type & Application
- 3.7 Global Placenta Growth Factor Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Placenta Growth Factor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Placenta Growth Factor Players Market Share by Revenue in 2025
- 3.8.3 2025 Placenta Growth Factor Tier 1, Tier 2, and Tier 3
4 Placenta Growth Factor Regional Status and Outlook
- 4.1 Global Placenta Growth Factor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Placenta Growth Factor Historic Market Size by Region
- 4.2.1 Global Placenta Growth Factor Sales in Volume by Region (2021-2026)
- 4.2.2 Global Placenta Growth Factor Sales in Value by Region (2021-2026)
- 4.2.3 Global Placenta Growth Factor Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Placenta Growth Factor Forecasted Market Size by Region
- 4.3.1 Global Placenta Growth Factor Sales in Volume by Region (2027-2032)
- 4.3.2 Global Placenta Growth Factor Sales in Value by Region (2027-2032)
- 4.3.3 Global Placenta Growth Factor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Placenta Growth Factor by Application
- 5.1 Placenta Growth Factor Market by Application
- 5.1.1 Neovascular Glaucoma
- 5.1.2 Myopia
- 5.1.3 Branch Retinal Vein Occlusion
- 5.1.4 Others
- 5.2 Global Placenta Growth Factor Market Size by Application
- 5.2.1 Global Placenta Growth Factor Market Size Overview by Application (2021-2032)
- 5.2.2 Global Placenta Growth Factor Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Placenta Growth Factor Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Placenta Growth Factor Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Placenta Growth Factor Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Placenta Growth Factor Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Placenta Growth Factor Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Placenta Growth Factor Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Alteogen Inc.
- 6.1.1 Alteogen Inc. Company Information
- 6.1.2 Alteogen Inc. Business Overview
- 6.1.3 Alteogen Inc. Placenta Growth Factor Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Alteogen Inc. Placenta Growth Factor Product Portfolio
- 6.1.5 Alteogen Inc. Recent Developments
- 6.2 Clearside BioMedical, Inc.
- 6.2.1 Clearside BioMedical, Inc. Company Information
- 6.2.2 Clearside BioMedical, Inc. Business Overview
- 6.2.3 Clearside BioMedical, Inc. Placenta Growth Factor Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Clearside BioMedical, Inc. Placenta Growth Factor Product Portfolio
- 6.2.5 Clearside BioMedical, Inc. Recent Developments
- 6.3 Formycon AG
- 6.3.1 Formycon AG Company Information
- 6.3.2 Formycon AG Business Overview
- 6.3.3 Formycon AG Placenta Growth Factor Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Formycon AG Placenta Growth Factor Product Portfolio
- 6.3.5 Formycon AG Recent Developments
- 6.4 Regeneron Pharmaceuticals Inc
- 6.4.1 Regeneron Pharmaceuticals Inc Company Information
- 6.4.2 Regeneron Pharmaceuticals Inc Business Overview
- 6.4.3 Regeneron Pharmaceuticals Inc Placenta Growth Factor Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Regeneron Pharmaceuticals Inc Placenta Growth Factor Product Portfolio
- 6.4.5 Regeneron Pharmaceuticals Inc Recent Developments
- 6.5 ThromboGenics NV
- 6.5.1 ThromboGenics NV Company Information
- 6.5.2 ThromboGenics NV Business Overview
- 6.5.3 ThromboGenics NV Placenta Growth Factor Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 ThromboGenics NV Placenta Growth Factor Product Portfolio
- 6.5.5 ThromboGenics NV Recent Developments
- 6.6 Chengdu Kanghong Pharmaceuticals Group Co Ltd
- 6.6.1 Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Information
- 6.6.2 Chengdu Kanghong Pharmaceuticals Group Co Ltd Business Overview
- 6.6.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Product Portfolio
- 6.6.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd Recent Developments
7 North America by Country
- 7.1 North America Placenta Growth Factor Sales by Country
- 7.1.1 North America Placenta Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Placenta Growth Factor Sales by Country (2021-2026)
- 7.1.3 North America Placenta Growth Factor Sales Forecast by Country (2027-2032)
- 7.2 North America Placenta Growth Factor Market Size by Country
- 7.2.1 North America Placenta Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Placenta Growth Factor Market Size by Country (2021-2026)
- 7.2.3 North America Placenta Growth Factor Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Placenta Growth Factor Sales by Country
- 8.1.1 Europe Placenta Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Placenta Growth Factor Sales by Country (2021-2026)
- 8.1.3 Europe Placenta Growth Factor Sales Forecast by Country (2027-2032)
- 8.2 Europe Placenta Growth Factor Market Size by Country
- 8.2.1 Europe Placenta Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Placenta Growth Factor Market Size by Country (2021-2026)
- 8.2.3 Europe Placenta Growth Factor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Placenta Growth Factor Sales by Country
- 9.1.1 Asia-Pacific Placenta Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Placenta Growth Factor Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Placenta Growth Factor Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Placenta Growth Factor Market Size by Country
- 9.2.1 Asia-Pacific Placenta Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Placenta Growth Factor Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Placenta Growth Factor Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Placenta Growth Factor Sales by Country
- 10.1.1 South America Placenta Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Placenta Growth Factor Sales by Country (2021-2026)
- 10.1.3 South America Placenta Growth Factor Sales Forecast by Country (2027-2032)
- 10.2 South America Placenta Growth Factor Market Size by Country
- 10.2.1 South America Placenta Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Placenta Growth Factor Market Size by Country (2021-2026)
- 10.2.3 South America Placenta Growth Factor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Placenta Growth Factor Sales by Country
- 11.1.1 Middle East and Africa Placenta Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Placenta Growth Factor Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Placenta Growth Factor Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Placenta Growth Factor Market Size by Country
- 11.2.1 Middle East and Africa Placenta Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Placenta Growth Factor Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Placenta Growth Factor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Placenta Growth Factor Value Chain Analysis
- 12.1.1 Placenta Growth Factor Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Placenta Growth Factor Production Mode & Process
- 12.2 Placenta Growth Factor Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Placenta Growth Factor Distributors
- 12.2.3 Placenta Growth Factor Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst